Global Angiotensin Receptor Blockers (ARBs) Sales Market Report 2021

Publisher Name :
Date: 04-May-2021
No. of pages: 125
Inquire Before Buying

The global Angiotensin Receptor Blockers (ARBs) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Angiotensin Receptor Blockers (ARBs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Valsartan

- Telmisartan

- Losartan

- Irbesartan

- Azilsartan

- Olmesartan

Segment by Application

- Hypertension

- Cardiovascular Diseases

- Kidney Diseases

- Other

The Angiotensin Receptor Blockers (ARBs) market is analysed and market size information is provided by regions (countries). Segment by Application, the Angiotensin Receptor Blockers (ARBs) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Pfizer

- Novartis

- Merck

- Astra Zeneca

- Jhonson and Johnson

- Eli Lilly

- Sanofi

- Bristol-Myers Squibb

- Bayer

- GSK

- Teva Pharmaceutical

Global Angiotensin Receptor Blockers (ARBs) Sales Market Report 2021

Table of Contents
1 Angiotensin Receptor Blockers (ARBs) Market Overview
1.1 Angiotensin Receptor Blockers (ARBs) Product Scope
1.2 Angiotensin Receptor Blockers (ARBs) Segment by Type
1.2.1 Global Angiotensin Receptor Blockers (ARBs) Sales by Type (2016 & 2021 & 2027)
1.2.2 Valsartan
1.2.3 Telmisartan
1.2.4 Losartan
1.2.5 Irbesartan
1.2.6 Azilsartan
1.2.7 Olmesartan
1.3 Angiotensin Receptor Blockers (ARBs) Segment by Application
1.3.1 Global Angiotensin Receptor Blockers (ARBs) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Angiotensin Receptor Blockers (ARBs) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Angiotensin Receptor Blockers (ARBs) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Angiotensin Receptor Blockers (ARBs) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Angiotensin Receptor Blockers (ARBs) Price Trends (2016-2027)
2 Angiotensin Receptor Blockers (ARBs) Estimates and Forecasts by Region
2.1 Global Angiotensin Receptor Blockers (ARBs) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Angiotensin Receptor Blockers (ARBs) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region (2016-2021)
2.2.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region (2016-2021)
2.3 Global Angiotensin Receptor Blockers (ARBs) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Angiotensin Receptor Blockers (ARBs) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Angiotensin Receptor Blockers (ARBs) Estimates and Projections (2016-2027)
2.4.2 Europe Angiotensin Receptor Blockers (ARBs) Estimates and Projections (2016-2027)
2.4.3 China Angiotensin Receptor Blockers (ARBs) Estimates and Projections (2016-2027)
2.4.4 Japan Angiotensin Receptor Blockers (ARBs) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Angiotensin Receptor Blockers (ARBs) Estimates and Projections (2016-2027)
2.4.6 India Angiotensin Receptor Blockers (ARBs) Estimates and Projections (2016-2027)
3 Global Angiotensin Receptor Blockers (ARBs) Competition Landscape by Players
3.1 Global Top Angiotensin Receptor Blockers (ARBs) Players by Sales (2016-2021)
3.2 Global Top Angiotensin Receptor Blockers (ARBs) Players by Revenue (2016-2021)
3.3 Global Angiotensin Receptor Blockers (ARBs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiotensin Receptor Blockers (ARBs) as of 2020)
3.4 Global Angiotensin Receptor Blockers (ARBs) Average Price by Company (2016-2021)
3.5 Manufacturers Angiotensin Receptor Blockers (ARBs) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Angiotensin Receptor Blockers (ARBs) Market Size by Type
4.1 Global Angiotensin Receptor Blockers (ARBs) Historic Market Review by Type (2016-2021)
4.1.1 Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2016-2021)
4.1.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Type (2016-2021)
4.1.3 Global Angiotensin Receptor Blockers (ARBs) Price by Type (2016-2021)
4.2 Global Angiotensin Receptor Blockers (ARBs) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Type (2022-2027)
4.2.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Type (2022-2027)
4.2.3 Global Angiotensin Receptor Blockers (ARBs) Price Forecast by Type (2022-2027)
5 Global Angiotensin Receptor Blockers (ARBs) Market Size by Application
5.1 Global Angiotensin Receptor Blockers (ARBs) Historic Market Review by Application (2016-2021)
5.1.1 Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2016-2021)
5.1.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Application (2016-2021)
5.1.3 Global Angiotensin Receptor Blockers (ARBs) Price by Application (2016-2021)
5.2 Global Angiotensin Receptor Blockers (ARBs) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Application (2022-2027)
5.2.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Application (2022-2027)
5.2.3 Global Angiotensin Receptor Blockers (ARBs) Price Forecast by Application (2022-2027)
6 North America Angiotensin Receptor Blockers (ARBs) Market Facts & Figures
6.1 North America Angiotensin Receptor Blockers (ARBs) Sales by Company
6.1.1 North America Angiotensin Receptor Blockers (ARBs) Sales by Company (2016-2021)
6.1.2 North America Angiotensin Receptor Blockers (ARBs) Revenue by Company (2016-2021)
6.2 North America Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type
6.2.1 North America Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type (2016-2021)
6.2.2 North America Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type (2022-2027)
6.3 North America Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Application
6.3.1 North America Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Application (2016-2021)
6.3.2 North America Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Application (2022-2027)
7 Europe Angiotensin Receptor Blockers (ARBs) Market Facts & Figures
7.1 Europe Angiotensin Receptor Blockers (ARBs) Sales by Company
7.1.1 Europe Angiotensin Receptor Blockers (ARBs) Sales by Company (2016-2021)
7.1.2 Europe Angiotensin Receptor Blockers (ARBs) Revenue by Company (2016-2021)
7.2 Europe Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type
7.2.1 Europe Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type (2022-2027)
7.3 Europe Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Application
7.3.1 Europe 125 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 125 Sales Breakdown by Application (2022-2027)
8 China Angiotensin Receptor Blockers (ARBs) Market Facts & Figures
8.1 China Angiotensin Receptor Blockers (ARBs) Sales by Company
8.1.1 China Angiotensin Receptor Blockers (ARBs) Sales by Company (2016-2021)
8.1.2 China Angiotensin Receptor Blockers (ARBs) Revenue by Company (2016-2021)
8.2 China Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type
8.2.1 China Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type (2016-2021)
8.2.2 China Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type (2022-2027)
8.3 China Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Application
8.3.1 China 154 Sales Breakdown by Application (2016-2021)
8.3.2 China 154 Sales Breakdown by Application (2022-2027)
9 Japan Angiotensin Receptor Blockers (ARBs) Market Facts & Figures
9.1 Japan Angiotensin Receptor Blockers (ARBs) Sales by Company
9.1.1 Japan Angiotensin Receptor Blockers (ARBs) Sales by Company (2016-2021)
9.1.2 Japan Angiotensin Receptor Blockers (ARBs) Revenue by Company (2016-2021)
9.2 Japan Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type
9.2.1 Japan Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type (2022-2027)
9.3 Japan Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Angiotensin Receptor Blockers (ARBs) Market Facts & Figures
10.1 Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales by Company
10.1.1 Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales by Company (2016-2021)
10.1.2 Southeast Asia Angiotensin Receptor Blockers (ARBs) Revenue by Company (2016-2021)
10.2 Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type
10.2.1 Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Angiotensin Receptor Blockers (ARBs) Market Facts & Figures
11.1 India Angiotensin Receptor Blockers (ARBs) Sales by Company
11.1.1 India Angiotensin Receptor Blockers (ARBs) Sales by Company (2016-2021)
11.1.2 India Angiotensin Receptor Blockers (ARBs) Revenue by Company (2016-2021)
11.2 India Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type
11.2.1 India Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type (2016-2021)
11.2.2 India Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Type (2022-2027)
11.3 India Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Application
11.3.1 India Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Application (2016-2021)
11.3.2 India Angiotensin Receptor Blockers (ARBs) Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Angiotensin Receptor Blockers (ARBs) Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Angiotensin Receptor Blockers (ARBs) Products Offered
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Angiotensin Receptor Blockers (ARBs) Products Offered
12.2.5 Novartis Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Angiotensin Receptor Blockers (ARBs) Products Offered
12.3.5 Merck Recent Development
12.4 Astra Zeneca
12.4.1 Astra Zeneca Corporation Information
12.4.2 Astra Zeneca Business Overview
12.4.3 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Products Offered
12.4.5 Astra Zeneca Recent Development
12.5 Jhonson and Johnson
12.5.1 Jhonson and Johnson Corporation Information
12.5.2 Jhonson and Johnson Business Overview
12.5.3 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Products Offered
12.5.5 Jhonson and Johnson Recent Development
12.6 Eli Lilly
12.6.1 Eli Lilly Corporation Information
12.6.2 Eli Lilly Business Overview
12.6.3 Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Eli Lilly Angiotensin Receptor Blockers (ARBs) Products Offered
12.6.5 Eli Lilly Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Business Overview
12.7.3 Sanofi Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sanofi Angiotensin Receptor Blockers (ARBs) Products Offered
12.7.5 Sanofi Recent Development
12.8 Bristol-Myers Squibb
12.8.1 Bristol-Myers Squibb Corporation Information
12.8.2 Bristol-Myers Squibb Business Overview
12.8.3 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Products Offered
12.8.5 Bristol-Myers Squibb Recent Development
12.9 Bayer
12.9.1 Bayer Corporation Information
12.9.2 Bayer Business Overview
12.9.3 Bayer Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Bayer Angiotensin Receptor Blockers (ARBs) Products Offered
12.9.5 Bayer Recent Development
12.10 GSK
12.10.1 GSK Corporation Information
12.10.2 GSK Business Overview
12.10.3 GSK Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 GSK Angiotensin Receptor Blockers (ARBs) Products Offered
12.10.5 GSK Recent Development
12.11 Teva Pharmaceutical
12.11.1 Teva Pharmaceutical Corporation Information
12.11.2 Teva Pharmaceutical Business Overview
12.11.3 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Products Offered
12.11.5 Teva Pharmaceutical Recent Development
13 Angiotensin Receptor Blockers (ARBs) Manufacturing Cost Analysis
13.1 Angiotensin Receptor Blockers (ARBs) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Angiotensin Receptor Blockers (ARBs)
13.4 Angiotensin Receptor Blockers (ARBs) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Angiotensin Receptor Blockers (ARBs) Distributors List
14.3 Angiotensin Receptor Blockers (ARBs) Customers
15 Market Dynamics
15.1 Angiotensin Receptor Blockers (ARBs) Market Trends
15.2 Angiotensin Receptor Blockers (ARBs) Drivers
15.3 Angiotensin Receptor Blockers (ARBs) Market Challenges
15.4 Angiotensin Receptor Blockers (ARBs) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Angiotensin Receptor Blockers (ARBs) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Angiotensin Receptor Blockers (ARBs) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Angiotensin Receptor Blockers (ARBs) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Region (2016-2021)
Table 5. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region (2016-2021)
Table 6. Global Angiotensin Receptor Blockers (ARBs) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Region (2016-2021)
Table 8. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Angiotensin Receptor Blockers (ARBs) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Angiotensin Receptor Blockers (ARBs) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Company (2016-2021)
Table 14. Global Angiotensin Receptor Blockers (ARBs) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Company (2016-2021)
Table 16. Global Angiotensin Receptor Blockers (ARBs) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin Receptor Blockers (ARBs) as of 2020)
Table 17. Global Angiotensin Receptor Blockers (ARBs) Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Angiotensin Receptor Blockers (ARBs) Manufacturing Sites and Area Served
Table 19. Manufacturers Angiotensin Receptor Blockers (ARBs) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Type (2016-2021)
Table 22. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Type (2016-2021)
Table 23. Global Angiotensin Receptor Blockers (ARBs) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Angiotensin Receptor Blockers (ARBs) Price (USD/Unit) by Type (2016-2021)
Table 25. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Type (2022-2027)
Table 26. Global Angiotensin Receptor Blockers (ARBs) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Type (2022-2027)
Table 28. Global Angiotensin Receptor Blockers (ARBs) Price (USD/Unit) by Type (2022-2027)
Table 29. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Application (2016-2021)
Table 30. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Application (2016-2021)
Table 31. Global Angiotensin Receptor Blockers (ARBs) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Angiotensin Receptor Blockers (ARBs) Price (USD/Unit) by Application (2016-2021)
Table 33. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Application (2022-2027)
Table 34. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Application (2022-2027)
Table 35. Global Angiotensin Receptor Blockers (ARBs) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Application (2022-2027)
Table 37. Global Angiotensin Receptor Blockers (ARBs) Price (USD/Unit) by Application (2022-2027)
Table 38. North America Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Company (2016-2021)
Table 39. North America Angiotensin Receptor Blockers (ARBs) Sales Market Share by Company (2016-2021)
Table 40. North America Angiotensin Receptor Blockers (ARBs) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Company (2016-2021)
Table 42. North America Angiotensin Receptor Blockers (ARBs) Sales by Type (2016-2021) & (K MT)
Table 43. North America Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2016-2021)
Table 44. North America Angiotensin Receptor Blockers (ARBs) Sales by Type (2022-2027) & (K MT)
Table 45. North America Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2022-2027)
Table 46. North America Angiotensin Receptor Blockers (ARBs) Sales by Application (2016-2021) & (K MT)
Table 47. North America Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2016-2021)
Table 48. North America Angiotensin Receptor Blockers (ARBs) Sales by Application (2022-2027) & (K MT)
Table 49. North America Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2022-2027)
Table 50. Europe Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Company (2016-2021)
Table 51. Europe Angiotensin Receptor Blockers (ARBs) Sales Market Share by Company (2016-2021)
Table 52. Europe Angiotensin Receptor Blockers (ARBs) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Company (2016-2021)
Table 54. Europe Angiotensin Receptor Blockers (ARBs) Sales by Type (2016-2021) & (K MT)
Table 55. Europe Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2016-2021)
Table 56. Europe Angiotensin Receptor Blockers (ARBs) Sales by Type (2022-2027) & (K MT)
Table 57. Europe Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2022-2027)
Table 58. Europe Angiotensin Receptor Blockers (ARBs) Sales by Application (2016-2021) & (K MT)
Table 59. Europe Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2016-2021)
Table 60. Europe Angiotensin Receptor Blockers (ARBs) Sales by Application (2022-2027) & (K MT)
Table 61. Europe Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2022-2027)
Table 62. China Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Company (2016-2021)
Table 63. China Angiotensin Receptor Blockers (ARBs) Sales Market Share by Company (2016-2021)
Table 64. China Angiotensin Receptor Blockers (ARBs) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Company (2016-2021)
Table 66. China Angiotensin Receptor Blockers (ARBs) Sales by Type (2016-2021) & (K MT)
Table 67. China Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2016-2021)
Table 68. China Angiotensin Receptor Blockers (ARBs) Sales by Type (2022-2027) & (K MT)
Table 69. China Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2022-2027)
Table 70. China Angiotensin Receptor Blockers (ARBs) Sales by Application (2016-2021) & (K MT)
Table 71. China Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2016-2021)
Table 72. China Angiotensin Receptor Blockers (ARBs) Sales by Application (2022-2027) & (K MT)
Table 73. China Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2022-2027)
Table 74. Japan Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Company (2016-2021)
Table 75. Japan Angiotensin Receptor Blockers (ARBs) Sales Market Share by Company (2016-2021)
Table 76. Japan Angiotensin Receptor Blockers (ARBs) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Company (2016-2021)
Table 78. Japan Angiotensin Receptor Blockers (ARBs) Sales by Type (2016-2021) & (K MT)
Table 79. Japan Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2016-2021)
Table 80. Japan Angiotensin Receptor Blockers (ARBs) Sales by Type (2022-2027) & (K MT)
Table 81. Japan Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2022-2027)
Table 82. Japan Angiotensin Receptor Blockers (ARBs) Sales by Application (2016-2021) & (K MT)
Table 83. Japan Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2016-2021)
Table 84. Japan Angiotensin Receptor Blockers (ARBs) Sales by Application (2022-2027) & (K MT)
Table 85. Japan Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Angiotensin Receptor Blockers (ARBs) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2022-2027)
Table 98. India Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Company (2016-2021)
Table 99. India Angiotensin Receptor Blockers (ARBs) Sales Market Share by Company (2016-2021)
Table 100. India Angiotensin Receptor Blockers (ARBs) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Company (2016-2021)
Table 102. India Angiotensin Receptor Blockers (ARBs) Sales by Type (2016-2021) & (K MT)
Table 103. India Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2016-2021)
Table 104. India Angiotensin Receptor Blockers (ARBs) Sales by Type (2022-2027) & (K MT)
Table 105. India Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2022-2027)
Table 106. India Angiotensin Receptor Blockers (ARBs) Sales by Application (2016-2021) & (K MT)
Table 107. India Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2016-2021)
Table 108. India Angiotensin Receptor Blockers (ARBs) Sales by Application (2022-2027) & (K MT)
Table 109. India Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2022-2027)
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Pfizer Angiotensin Receptor Blockers (ARBs) Product
Table 114. Pfizer Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Novartis Angiotensin Receptor Blockers (ARBs) Product
Table 119. Novartis Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Merck Angiotensin Receptor Blockers (ARBs) Product
Table 124. Merck Recent Development
Table 125. Astra Zeneca Corporation Information
Table 126. Astra Zeneca Description and Business Overview
Table 127. Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Astra Zeneca Angiotensin Receptor Blockers (ARBs) Product
Table 129. Astra Zeneca Recent Development
Table 130. Jhonson and Johnson Corporation Information
Table 131. Jhonson and Johnson Description and Business Overview
Table 132. Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Product
Table 134. Jhonson and Johnson Recent Development
Table 135. Eli Lilly Corporation Information
Table 136. Eli Lilly Description and Business Overview
Table 137. Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Eli Lilly Angiotensin Receptor Blockers (ARBs) Product
Table 139. Eli Lilly Recent Development
Table 140. Sanofi Corporation Information
Table 141. Sanofi Description and Business Overview
Table 142. Sanofi Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Sanofi Angiotensin Receptor Blockers (ARBs) Product
Table 144. Sanofi Recent Development
Table 145. Bristol-Myers Squibb Corporation Information
Table 146. Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Bristol-Myers Squibb Description and Business Overview
Table 148. Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Product
Table 149. Bristol-Myers Squibb Recent Development
Table 150. Bayer Corporation Information
Table 151. Bayer Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Bayer Description and Business Overview
Table 153. Bayer Angiotensin Receptor Blockers (ARBs) Product
Table 154. Bayer Recent Development
Table 155. GSK Corporation Information
Table 156. GSK Description and Business Overview
Table 157. GSK Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. GSK Angiotensin Receptor Blockers (ARBs) Product
Table 159. GSK Recent Development
Table 160. Teva Pharmaceutical Corporation Information
Table 161. Teva Pharmaceutical Description and Business Overview
Table 162. Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Product
Table 164. Teva Pharmaceutical Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Angiotensin Receptor Blockers (ARBs) Distributors List
Table 168. Angiotensin Receptor Blockers (ARBs) Customers List
Table 169. Angiotensin Receptor Blockers (ARBs) Market Trends
Table 170. Angiotensin Receptor Blockers (ARBs) Market Drivers
Table 171. Angiotensin Receptor Blockers (ARBs) Market Challenges
Table 172. Angiotensin Receptor Blockers (ARBs) Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiotensin Receptor Blockers (ARBs) Product Picture
Figure 2. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type in 2021 & 2027
Figure 3. Valsartan Product Picture
Figure 4. Telmisartan Product Picture
Figure 5. Losartan Product Picture
Figure 6. Irbesartan Product Picture
Figure 7. Azilsartan Product Picture
Figure 8. Olmesartan Product Picture
Figure 9. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application in 2021 & 2027
Figure 10. Hypertension Examples
Figure 11. Cardiovascular Diseases Examples
Figure 12. Kidney Diseases Examples
Figure 13. Other Examples
Figure 14. Global Angiotensin Receptor Blockers (ARBs) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) Growth Rate (2016-2027)
Figure 17. Global Angiotensin Receptor Blockers (ARBs) Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 18. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America Angiotensin Receptor Blockers (
  • Global Aspirin Enteric-Coated Tablets Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 120
    The global Aspirin Enteric-Coated Tablets market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Aspirin Enteric-Coated Tablets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - 81mg/Pc - 100mg......
  • Global Glucose Injection Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 113
    The global Glucose Injection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glucose Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - 5% Injection - 10% Injection - 50%......
  • Global Recombinant Peptide Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 119
    The global Recombinant Peptide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Peptide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Glucagon - Calcitonin - Other......
  • Global Sufentanil (API) Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 119
    The global Sufentanil (API) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sufentanil (API) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Purity 98% - Purity 99% Segm......
  • Global Human Fibrinogen Concentrate Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 119
    The global Human Fibrinogen Concentrate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Fibrinogen Concentrate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - 0.5g - 1.0g ......
  • Global Influenza Drugs Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 143
    The global Influenza Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Zanamivir - Oseltamivir Phosphate - Pe......
  • Global Pet Medication Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 142
    The global Pet Medication market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pet Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Antibiotics - Antifungal - Flea Products......
  • Global Barrier Membranes Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 146
    The global Barrier Membranes market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Barrier Membranes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Resorbable Membranes - Non-resorbable Mem......
  • Global Growth Hormone Drug Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 128
    The global Growth Hormone Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Growth Hormone Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Norditropin - Genotropin - Hum......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs